Comparing two polymeric biguanides: chemical distinction, antiseptic efficacy and cytotoxicity of polyaminopropyl biguanide and polyhexamethylene biguanide
In this study, polyaminopropyl biguanide (PAPB) was compared to the molecularly closely related polyhexamethylene biguanide (PHMB) with respect to chemical relationship, antiseptic efficacy and cytotoxicity in vitro. Cytotoxicity for human keratinocytes (HaCaTs) and murine fibroblasts (L929) was determined according to ISO EN 10993-5 for both substances. Antimicrobial efficacy tests were performed via determination of the MBC, quantitative suspension method for substances and investigation of two PAPB- or PHMB-containing dressings against Staphyloccoccus aureus, Escherichia coli and Pseudomonas aeruginosa, according to international standards. Prior mass spectrometry was performed for chemical differentiation of the investigated substances. PHMB showed high toxicity even in low concentrations for both tested cell lines and a high antimicrobial efficacy against S. aureus and E. coli. In the case of PAPB, no or only low cytotoxicity was detected after 72 h, whilst comparable antibacterial features are lacking, as PAPB showed no relevant antimicrobial effects. Even though chemically closely related, PAPB proved to be ineffective in bacterial eradication, whilst PHMB showed a high efficacy. The discovery and establishment of safe and effective alternative antiseptics are important issues for the treatment of infected wounds. In particular, rising bacterial resistances to established agents, as well as ongoing discussions of potential toxic or carcinogenic effects emphasize this necessity. Nevertheless, the presented results highlight that even small changes in the chemical structure of related agents such as PHMB and PAPB can dramatically affect their efficacy and, therefore, need to be carefully distinguished and assessed side by side.
BroxtonP.,
WoodcockP. M.,
GilbertP.1983; A study of the antibacterial activity of some polyhexamethylene biguanides towards Escherichia coli ATCC 8739. J Appl Bacteriol 54:345–353 [View Article][PubMed]
BroxtonP.,
WoodcockP. M.,
HeatleyF.,
GilbertP.1984a; Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli
. J Appl Bacteriol 57:115–124 [View Article][PubMed]
BroxtonP.,
WoodcockP. M.,
GilbertP.1984b; Binding of some polyhexamethylene biguanides to the cell envelope of Escherichia coli ATCC 8739. Microbios 41:15–22
BroxtonP.,
WoodcockP. M.,
GilbertP.1984c; Injury and recovery of Escherichia coli ATCC 8739 from treatment with some polyhexamethylene biguanides. Microbios 40:187–193
ChadeauE.,
DumasE.,
AdtI.,
DegraeveP.,
NoëlC.,
GirodetC.,
OulahalN.2012; Assessment of the mode of action of polyhexamethylene biguanide against Listeria innocua by Fourier transformed infrared spectroscopy and fluorescence anisotropy analysis. Can J Microbiol 58:1353–1361 [View Article][PubMed]
ChangJ. M.,
McCannaD. J.,
SubbaramanL. N.,
JonesL. W.2015; Efficacy of antimicrobials against biofilms of Achromobacter and Pseudomonas
. Optom Vis Sci 92:506–513 [View Article][PubMed]
ClappM. J. L.,
IswaranT. J.,
RowsonS. M.,
MajorT. M.1977bPolyhexamethylene Biguanide: Life-time Feeding Study in the Mouse. Report No. Ctl/P/332 Macclesfield, UK: Central Toxicology Laboratory;
CreppyE. E.,
DialloA.,
MoukhaS.,
Eklu-GadegbekuC.,
CrosD.2014; Study of epigenetic properties of poly(hexamethylene biguanide) hydrochloride (PHMB). Int J Environ Res Public Health 11:8069–8092 [View Article][PubMed]
DIN2009; EN 58940-7:2009-08 - Medical microbiology. Susceptibility testing of microbial pathogens to antimicrobial agents - Part 7: Determination of the minimum bactericidal concentration (MBC) with the method of microbouillon dilution. (Text in German and English).
DIN2012; EN 13727:2012+A1:2013 - Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of bactericidal activity in the medical area – (Test method and requirements (phase 2, step 1) (German version).
ECHA/RAC2011Opinion proposing harmonised classification and labelling at community level of polyhexamethylene biguanide or poly(hexamethylene) biguanidehydrochloride or PHMB Helsinki, Finland: European Chemicals Agency;
HübnerN. O.,
KramerA.2010; Review on the efficacy, safety and clinical applications of polihexanide, a modern wound antiseptic. Skin Pharmacol Physiol 23:17–27 [View Article][PubMed]
IkedaT.,
TazukeS.,
WatanabeM.1983; Interaction of biologically active molecules with phospholipid membranes. I. Fluorescence depolarization studies on the effect of polymeric biocide bearing biguanide groups in the main chain. Biochim Biophys Acta 735:380–386[PubMed][CrossRef]
IkedaT.,
TazukeS.,
BamfordC. H.1985a; Interaction of membrane active biguanides with negatively charged species. A model for their interaction with target sites in microbial membranes. J Chem Res 6:180–181
IkedaT.,
TazukeS.,
BamfordC. H.,
LedwithA.1985b; Spectroscopic studies on the interaction of polymeric in-chain biguanide biocide with phospholipid membranes as probed by 8-anilinonaphthalene-1-sulfonate. Bull Chem Soc Jpn 58:705–709 [View Article]
ISO2009EN 10993-5:2009 - Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009) (German version) Geneva, Switzerland: International Organization for Standardization;
ISO2012prEN 20743:2012 - Textiles - Determination of antibacterial activity of textile products (ISO/DIS 20743:2012) German version Geneva, Switzerland: International Organization for Standardization;
KapalschinskiN.,
SeippH. M.,
OnderdonkA. B.,
GoertzO.,
DaigelerA.,
LahmerA.,
LehnhardtM.,
HirschT.2013; Albumin reduces the antibacterial activity of polyhexanide-biguanide-based antiseptics against Staphylococcus aureus and MRSA. Burns 39:1221–1225 [View Article][PubMed]
LibbyG.,
DonnellyL. A.,
DonnanP. T.,
AlessiD. R.,
MorrisA. D.,
EvansJ. M.2009; New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32:1620–1625 [View Article][PubMed]
MilburnG. M.1996Polyhexamethylene Biguanide: Two Year Oncogenic Study in Mice. Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, UK. Report No. Ctl/P/4649 Macclesfield, UK: Central Toxicology Laboratory;
MüllerG.,
KramerA.2008; Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 61:1281–1287 [View Article][PubMed]
ReindelW.,
MercheaM. M.,
RahM. J.,
ZhangL.2013; Meta-analysis of the ocular biocompatibility of a new multipurpose lens care system. Clin Ophthalmol 7:2051–2056 [View Article][PubMed]
SCCS2014Opinion on the Safety of Poly(hexamethylene) Biguanide Hydrochloride or Polyaminopropyl Biguanide (PHMB) in Cosmetic Products. SCCS/1535/14 Revision Of 16 Brussels, Belgium: Scientific Committee on Consumer Safety;
SuttonS. V.,
FrancoR. J.,
PorterD. A.,
Mowrey-McKeeM. F.,
BusschaertS. C.,
HambergerJ. F.,
ProudD. W.1991; D-value determinations are an inappropriate measure of disinfecting activity of common contact lens disinfecting solutions. Appl Environ Microbiol 57:2021–2026[PubMed]
SütterlinS.,
TanoE.,
BergstenA.,
TallbergA. B.,
MelhusA.2012; Effects of silver-based wound dressings on the bacterial flora in chronic leg ulcers and its susceptibility in vitro to silver. Acta Derm Venereol 92:34–39 [View Article][PubMed]
WiegandC.,
HeinzeT.,
HiplerU.-C.2009; Comparative in vitro study on cytotoxicity, antimicrobial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver-containing alginate. Wound Repair Regen 17:511–521 [View Article][PubMed]
Comparing two polymeric biguanides: chemical distinction, antiseptic efficacy and cytotoxicity of polyaminopropyl biguanide and polyhexamethylene biguanide